| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $1.2M | -88.2% | -91.6% |
| SG&A Expense | $1.9M | +5.6% | -34.7% |
| Operating Income | -$3.2M | +81.2% | +82.3% |
| Pre-tax Income | -$3.1M | +81.4% | +82.2% |
| Income Tax | $202K | — | -71.5% |
| Net Income | -$3.3M | +80.2% | +81.8% |
| EPS (Basic) | -$0.08 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.7M | -46.6% | -84.6% |
| Current Assets | $10.5M | -45.2% | -83.5% |
| Total Assets | $11.4M | -43.1% | -82.5% |
| Current Liabilities | $8.7M | -39.2% | -45.9% |
| Total Liabilities | $8.7M | — | -45.9% |
| Stockholders' Equity | $2.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$37.3M | — | — |
| Financing Cash Flow | -$301K | — | — |
| +80.0% |
| +81.8% |
| EPS (Diluted) | -$0.08 | +80.0% | +81.8% |
| -52.9% |
| -94.5% |